Máj- és epeúti rák: vizsgálatok itt: Portugália
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- No phaseTaking peopleObservational Study Protocol: LIVER-R
- Where
- Faro, Lisbon, Vila Real
- Életkor
- 18 év to 130 év
- People
- 4000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06252753 - 3. fázisTaking peopleEfficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- Where
- Almada, Coimbra, Lisbon, Porto
- Életkor
- 18 év and over
- People
- 286 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT06282575 · EU 2023-508219-21-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Lisbon, Porto
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 1. fázisTaking peopleA Study of ZW251 in Participants With Advanced Solid Tumors
- Where
- Lisbon, Vila Nova de Gaia
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Zymeworks BC Inc.
See details and how to joinNCT07164313 - 2. fázisTaking peopleStudy of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
- Where
- Lisbon
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT05727176 · EU 2023-503665-39-00 - 3. fázisTaking peopleA Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician’s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR) altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma (FIRST-308)
- Where
- Lisbon
- Életkor
- 18 év and over
- People
- 126 worldwide
- Run by
- Transthera Sciences (Nanjing) Inc.
See details and how to join2023-505660-11-00 · EU 2023-505660-11-00 - 4. fázisTaking peopleHOPE Against Cancer Recurrence in HCC
- Where
- Lisbon
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Philipp Dutkowski
See details and how to joinNCT06717919 - No phaseTaking peopleThe European NAFLD Registry
- Where
- Lisbon
- Életkor
- 18 év to 100 év
- People
- 10 000 worldwide
- Run by
- Newcastle University
See details and how to joinNCT04442334 - No phaseTaking peopleHepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma
- Where
- Lisbon
- Életkor
- 18 év to 70 év
- People
- 40
- Run by
- Centro Hospitalar de Lisboa Central
See details and how to joinNCT04499833